首页 > 最新文献

Clinical Neuroradiology最新文献

英文 中文
Supra-tentorial Ependymomas with ZFTA Fusion, YAP1 Fusion, and Astroblastomas, MN1-altered: Characteristic Imaging Features. 伴有 ZFTA 融合、YAP1 融合和星形母细胞瘤(MN1-altered)的幕上癫痫瘤:影像学特征。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-02 DOI: 10.1007/s00062-024-01444-w
Victoire Perrod, Raphael Levy, Arnault Tauziède-Espariat, Charles-Joris Roux, Kevin Beccaria, Thomas Blauwblomme, Jacques Grill, Christelle Dufour, Léa Guerrini-Rousseau, Samuel Abbou, Stéphanie Bolle, Alexandre Roux, Johan Pallud, Corentin Provost, Catherine Oppenheim, Pascale Varlet, Nathalie Boddaert, Volodia Dangouloff-Ros

Purpose: Supratentorial (ST) ependymoma subgroups are defined by two different fusions with different prognoses. Astroblastomas, MN1-altered, have ependymal-like histopathologic features and represent a differential diagnosis in children. We hypothesized that ZFTA-fused ependymoma and YAP1-fused ependymoma on the one hand, and astroblastoma, MN1-altered, on the other hand, show different MRI characteristics.

Methods: We retrospectively analyzed the preoperative imaging of 45 patients with ST ependymoma or astroblastoma between January 2000 and September 2020, blinded to histomolecular grouping. Several characteristics, such as location, tumor volume, calcifications, solid/cystic component, and signal enhancement or diffusion were evaluated. We compared imaging characteristics according to their molecular subtype (ZFTA-fused, YAP1-fused, and astroblastoma, MN1-altered).

Results: Thirty-nine patients were classified as having an ependymoma, 35 with a ZFTA fusion and four with a YAP1 fusion, and six as having an astroblastoma, MN1-altered. YAP1-fused ependymomas were more likely to involve at least 3 lobes than ZFTA-fused ependymomas. Astroblastomas were located in the frontal lobe in 100% of the tumors versus 49% of the ependymomas. Cerebral blood flow by arterial spin labeling was higher in astroblastomas than in ependymomas. There were no differences in the other characteristics between the molecular groups. All the tumors showed common features: intra-axial extra-ventricular tumors, very frequent contrast enhancement (39/43, 91%), a cystic/necrotic component (41/45, 91%), restricted diffusion (32/36, 89%), calcifications (15/18, 83%), and peri-tumoral edema (38/44, 86%).

Conclusion: The distinction between ST ependymoma subtypes and astroblastomas can be guided by several imaging features. These tumors share common imaging features that may help to differentiate ST ependymomas and astroblastomas from other pediatric ST tumors.

目的:脑室上(ST)外胚瘤亚组是由两种不同的融合定义的,其预后各不相同。星形母细胞瘤(MN1-altered)具有类似于肾上皮瘤的组织病理学特征,是儿童的一种鉴别诊断方法。我们假设,ZFTA融合的上皮瘤和YAP1融合的上皮瘤与MN1改变的成星形细胞瘤显示出不同的磁共振成像特征:我们回顾性分析了2000年1月至2020年9月期间45例ST型上皮瘤或星形母细胞瘤患者的术前成像,对组织分子分组进行了盲法分析。评估了一些特征,如位置、肿瘤体积、钙化、实性/囊性成分、信号增强或弥散。我们根据其分子亚型(ZFTA融合、YAP1融合和星形母细胞瘤、MN1改变)比较了成像特征:结果:39例患者被归类为上皮瘤,35例为ZFTA融合,4例为YAP1融合,6例为星形母细胞瘤,MN1改变。与ZFTA融合上皮瘤相比,YAP1融合上皮瘤更有可能累及至少3个叶。100%的星形母细胞瘤位于额叶,而49%的脑外胚瘤位于额叶。通过动脉自旋标记法测定,星形母细胞瘤的脑血流量高于附肢瘤。分子组之间的其他特征没有差异。所有肿瘤都显示出共同特征:轴外肿瘤、非常频繁的造影剂增强(39/43,91%)、囊肿/坏死成分(41/45,91%)、弥散受限(32/36,89%)、钙化(15/18,83%)和瘤周水肿(38/44,86%):结论:ST 上皮瘤亚型与星形母细胞瘤之间的区别可以通过几个影像学特征来指导。这些肿瘤具有共同的影像学特征,有助于将ST后胚骺瘤和星形母细胞瘤与其他儿科ST肿瘤区分开来。
{"title":"Supra-tentorial Ependymomas with ZFTA Fusion, YAP1 Fusion, and Astroblastomas, MN1-altered: Characteristic Imaging Features.","authors":"Victoire Perrod, Raphael Levy, Arnault Tauziède-Espariat, Charles-Joris Roux, Kevin Beccaria, Thomas Blauwblomme, Jacques Grill, Christelle Dufour, Léa Guerrini-Rousseau, Samuel Abbou, Stéphanie Bolle, Alexandre Roux, Johan Pallud, Corentin Provost, Catherine Oppenheim, Pascale Varlet, Nathalie Boddaert, Volodia Dangouloff-Ros","doi":"10.1007/s00062-024-01444-w","DOIUrl":"10.1007/s00062-024-01444-w","url":null,"abstract":"<p><strong>Purpose: </strong>Supratentorial (ST) ependymoma subgroups are defined by two different fusions with different prognoses. Astroblastomas, MN1-altered, have ependymal-like histopathologic features and represent a differential diagnosis in children. We hypothesized that ZFTA-fused ependymoma and YAP1-fused ependymoma on the one hand, and astroblastoma, MN1-altered, on the other hand, show different MRI characteristics.</p><p><strong>Methods: </strong>We retrospectively analyzed the preoperative imaging of 45 patients with ST ependymoma or astroblastoma between January 2000 and September 2020, blinded to histomolecular grouping. Several characteristics, such as location, tumor volume, calcifications, solid/cystic component, and signal enhancement or diffusion were evaluated. We compared imaging characteristics according to their molecular subtype (ZFTA-fused, YAP1-fused, and astroblastoma, MN1-altered).</p><p><strong>Results: </strong>Thirty-nine patients were classified as having an ependymoma, 35 with a ZFTA fusion and four with a YAP1 fusion, and six as having an astroblastoma, MN1-altered. YAP1-fused ependymomas were more likely to involve at least 3 lobes than ZFTA-fused ependymomas. Astroblastomas were located in the frontal lobe in 100% of the tumors versus 49% of the ependymomas. Cerebral blood flow by arterial spin labeling was higher in astroblastomas than in ependymomas. There were no differences in the other characteristics between the molecular groups. All the tumors showed common features: intra-axial extra-ventricular tumors, very frequent contrast enhancement (39/43, 91%), a cystic/necrotic component (41/45, 91%), restricted diffusion (32/36, 89%), calcifications (15/18, 83%), and peri-tumoral edema (38/44, 86%).</p><p><strong>Conclusion: </strong>The distinction between ST ependymoma subtypes and astroblastomas can be guided by several imaging features. These tumors share common imaging features that may help to differentiate ST ependymomas and astroblastomas from other pediatric ST tumors.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"939-950"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment. 尼莫地平作为血管扩张剂用于导引导管冲洗,以防止血管内卒中治疗过程中的血管痉挛。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-05-31 DOI: 10.1007/s00062-024-01424-0
Louisa J Sommer, Jessica Jesser, Omid Nikoubashman, Thanh N Nguyen, Joao Pinho, Arno Reich, Martin Wiesmann, Charlotte S Weyland

Purpose: The clinical importance and management of vasospasm as a complication during endovascular stroke treatment (EVT) has not been well studied. We sought to investigate the effect of adding nimodipine to the guiding catheter flush (GCF) to prevent vasospasm during EVT.

Methods: This is a single-center retrospective analysis including patients with EVT (stent-retriever and/or distal aspiration) treated for anterior or posterior circulation intracranial vessel occlusion from January 2018 to June 2023. Exclusion criteria were intracranial or extracranial stenosis, intra-arterial alteplase, patient age over 80 years. Study groups were patients with (nimo+) and without (nimo-) nimodipine in the GCF. They were compared for occurrence of vasospasm as primary endpoint and clinical outcome in univariate analysis.

Results: 477 patients were included in the analysis (nimo+ n = 94 vs. nimo- n = 383). Nimo+ patients experienced less vasospasm during EVT (e.g. vasospasm in target vessel n (%): nimo- = 113 (29.6) vs. nimo+ = 9 (9.6), p < 0.001; extracranial vasospasm, n (%): nimo- = 68 (17.8) vs. nimo+ = 7 (7.4), p = 0.017). Patients of the two study groups had a comparable clinical outcome (90 day mRS, median (IQR): 3 (1-6) for both groups, p = 0.896). In general, patients with anterior circulation target vessel occlusion (TVO) experienced more vasospasm (anterior circ. TVO 38.7% vs. posterior circ. 7.5%, p = 0.006).

Conclusion: Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation TVO.

目的:血管痉挛是血管内卒中治疗(EVT)过程中的一种并发症,其临床重要性和处理方法尚未得到充分研究。我们试图研究在导引导管冲洗液(GCF)中加入尼莫地平以预防 EVT 期间血管痉挛的效果:这是一项单中心回顾性分析,包括2018年1月至2023年6月期间因前循环或后循环颅内血管闭塞而接受EVT(支架截流术和/或远端抽吸术)治疗的患者。排除标准为颅内或颅外血管狭窄、动脉内阿替普酶、患者年龄超过80岁。研究组为在 GCF 中使用(尼莫+)和未使用(尼莫-)尼莫地平的患者。在单变量分析中比较了作为主要终点的血管痉挛发生率和临床结果:分析共纳入 477 名患者(尼莫+ n = 94 对尼莫- n = 383)。Nimo+患者在EVT期间经历的血管痉挛较少(如靶血管血管痉挛n(%):nimo- = 113 (29.6) vs. nimo+ = 9 (9.6),p 结论:Nimo+患者在EVT期间经历的血管痉挛较少:预防性添加尼莫地平可降低 EVT 期间血管痉挛的风险,且不会影响临床结果。与后循环 TVO 相比,前循环 TVO 患者经历的血管痉挛更多。
{"title":"Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment.","authors":"Louisa J Sommer, Jessica Jesser, Omid Nikoubashman, Thanh N Nguyen, Joao Pinho, Arno Reich, Martin Wiesmann, Charlotte S Weyland","doi":"10.1007/s00062-024-01424-0","DOIUrl":"10.1007/s00062-024-01424-0","url":null,"abstract":"<p><strong>Purpose: </strong>The clinical importance and management of vasospasm as a complication during endovascular stroke treatment (EVT) has not been well studied. We sought to investigate the effect of adding nimodipine to the guiding catheter flush (GCF) to prevent vasospasm during EVT.</p><p><strong>Methods: </strong>This is a single-center retrospective analysis including patients with EVT (stent-retriever and/or distal aspiration) treated for anterior or posterior circulation intracranial vessel occlusion from January 2018 to June 2023. Exclusion criteria were intracranial or extracranial stenosis, intra-arterial alteplase, patient age over 80 years. Study groups were patients with (nimo+) and without (nimo-) nimodipine in the GCF. They were compared for occurrence of vasospasm as primary endpoint and clinical outcome in univariate analysis.</p><p><strong>Results: </strong>477 patients were included in the analysis (nimo+ n = 94 vs. nimo- n = 383). Nimo+ patients experienced less vasospasm during EVT (e.g. vasospasm in target vessel n (%): nimo- = 113 (29.6) vs. nimo+ = 9 (9.6), p < 0.001; extracranial vasospasm, n (%): nimo- = 68 (17.8) vs. nimo+ = 7 (7.4), p = 0.017). Patients of the two study groups had a comparable clinical outcome (90 day mRS, median (IQR): 3 (1-6) for both groups, p = 0.896). In general, patients with anterior circulation target vessel occlusion (TVO) experienced more vasospasm (anterior circ. TVO 38.7% vs. posterior circ. 7.5%, p = 0.006).</p><p><strong>Conclusion: </strong>Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation TVO.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"809-815"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Y Stent-Assisted Coiling Technique for Bifurcation Aneurysms Using Double Neuroform® Stent: a Large Restrospective Series. 使用双 Neuroform® 支架治疗分叉动脉瘤的 Y 支架辅助夹闭技术:大型回顾性系列研究。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-18 DOI: 10.1007/s00062-024-01437-9
Isabel Rodriguez Caamaño, Sebastián Remollo, Mikel Terceño, Alberto Blanco, Saima Bashir, Carlos Castaño

Background: Stent assisted coiling technique have shown to be an effective and safe endovascular strategy for wide neck bifurcation aneurysms in achieving greater packing, allowing the closure of the aneurysm and preserving the parent arteries, compared to simple coiling.

Material and methods: We conducted a retrospective analysis of 79 patients with cerebral aneurysms treated using 'Y'-configuration double Neuroform® stent-assisted coiling at our center from July 2009 to July 2022.

Results: Of the 79 patients, 76% (60/79) were incidental unruptured cerebral aneurysm and 24% were patients treated for aneurysm recanalization of a previous ruptured aneurysm (19/79). The most frequent locations were anterior communicating artery (AComA) 44.3% (35/79) and middle cerebral artery (MCA) 32.9% (26/79). We found a complete and almost complete aneurysm occlusion (Raymond-Roy occlusion classification (RROC) 1 and 2): in 100% (79/79) in the angiography after procedure, in 97.6% (42/43) at the first follow-up at 6-8 months and 100% (57/57) at the first 1-2 years of follow-up. No mortality related to treatment was detected. We registered 2.5% (2/79) major ipsilateral strokes, one due to acute in stent thrombosis (patient had a mRS: 0 in follow up at 90 days) and a spinal anterior artery occlusion (patient had a mRS: 3 in follow up at 90 days).

Conclusion: The 'Y' stent-assisted coiling technique with double Neuroform® is a safe and effective technique for the treatment of wide-neck bifurcation aneurysms, with high rates of complete occlusion, preserving the permeability of the afferent and efferent arteries and low rate of complications.

背景:与简单的卷紮相比,支架辅助卷紮技术是治疗宽颈分叉动脉瘤的一种有效而安全的血管内治疗策略,它能获得更多的填塞,使动脉瘤闭合,并保留母动脉:我们对2009年7月至2022年7月在本中心使用'Y'型配置双Neuroform®支架辅助卷曲术治疗的79例脑动脉瘤患者进行了回顾性分析:79例患者中,76%(60/79)为偶发性未破裂脑动脉瘤,24%(19/79)为先前破裂动脉瘤的动脉瘤再闭塞治疗患者。最常见的位置是前交通动脉(AComA)44.3%(35/79)和大脑中动脉(MCA)32.9%(26/79)。我们发现动脉瘤完全或几乎完全闭塞(Raymond-Roy 闭塞分类(RROC)1 和 2):术后血管造影中 100%(79/79)完全闭塞,6-8 个月首次随访中 97.6%(42/43)完全闭塞,1-2 年随访中 100%(57/57)完全闭塞。未发现与治疗相关的死亡率。我们记录了2.5%(2/79)的严重同侧中风,其中一次是由于支架内急性血栓形成(90天随访时患者的mRS为0),另一次是脊髓前动脉闭塞(90天随访时患者的mRS为3):结论:"Y "型支架辅助双Neuroform®卷绕技术是治疗宽颈分叉动脉瘤的一种安全有效的技术,完全闭塞率高,保留了传入和传出动脉的通透性,并发症发生率低。
{"title":"Y Stent-Assisted Coiling Technique for Bifurcation Aneurysms Using Double Neuroform® Stent: a Large Restrospective Series.","authors":"Isabel Rodriguez Caamaño, Sebastián Remollo, Mikel Terceño, Alberto Blanco, Saima Bashir, Carlos Castaño","doi":"10.1007/s00062-024-01437-9","DOIUrl":"10.1007/s00062-024-01437-9","url":null,"abstract":"<p><strong>Background: </strong>Stent assisted coiling technique have shown to be an effective and safe endovascular strategy for wide neck bifurcation aneurysms in achieving greater packing, allowing the closure of the aneurysm and preserving the parent arteries, compared to simple coiling.</p><p><strong>Material and methods: </strong>We conducted a retrospective analysis of 79 patients with cerebral aneurysms treated using 'Y'-configuration double Neuroform® stent-assisted coiling at our center from July 2009 to July 2022.</p><p><strong>Results: </strong>Of the 79 patients, 76% (60/79) were incidental unruptured cerebral aneurysm and 24% were patients treated for aneurysm recanalization of a previous ruptured aneurysm (19/79). The most frequent locations were anterior communicating artery (AComA) 44.3% (35/79) and middle cerebral artery (MCA) 32.9% (26/79). We found a complete and almost complete aneurysm occlusion (Raymond-Roy occlusion classification (RROC) 1 and 2): in 100% (79/79) in the angiography after procedure, in 97.6% (42/43) at the first follow-up at 6-8 months and 100% (57/57) at the first 1-2 years of follow-up. No mortality related to treatment was detected. We registered 2.5% (2/79) major ipsilateral strokes, one due to acute in stent thrombosis (patient had a mRS: 0 in follow up at 90 days) and a spinal anterior artery occlusion (patient had a mRS: 3 in follow up at 90 days).</p><p><strong>Conclusion: </strong>The 'Y' stent-assisted coiling technique with double Neuroform® is a safe and effective technique for the treatment of wide-neck bifurcation aneurysms, with high rates of complete occlusion, preserving the permeability of the afferent and efferent arteries and low rate of complications.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"919-928"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141635175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: a Retrospective, Multicenter Study. 分流装置治疗颈动脉侧壁颅内动脉瘤的疗效比较:一项回顾性多中心研究。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-18 DOI: 10.1007/s00062-024-01435-x
Adam A Dmytriw, Hamza Adel Salim, Basel Musmar, Nicole M Cancelliere, Christoph J Griessenauer, Robert W Regenhardt, Jesse Jones, Vincent Tutino, Zuha Hasan, Nicola Limbucci, Sovann V Lay, Julian Spears, James D Rabinov, Mark R Harrigan, Adnan H Siddiqui, Elad I Levy, Christopher J Stapleton, Leonardo Renieri, Christophe Cognard, Hamza Shaikh, Anna Luisa Kühn, Markus A Möhlenbruch, Stavropoula I Tjoumakaris, Pascal Jabbour, Philipp Taussky, Fabio Settecase, Manraj K S Heran, Anh Nguyen, David Volders, Pablo Harker, Diego A Devia, Ajit S Puri, Marios Psychogios, Juan C Puentes, Giuseppe Leone, Giuseppe Buono, Margherita Tarantino, Mario Muto, Francesco Briganti, Shamsher Dalal, Vamsi Gontu, Rodolfo E Alcedo Guardia, Juan C Vicenty-Padilla, Patrick Brouwer, Matthias H Schmidt, Clemens Schirmer, Gwynedd E Pickett, Tommy Andersson, Michael Söderman, Thomas R Marotta, Hugo Cuellar-Saenz, Ajith J Thomas, Aman B Patel, Vitor Mendes Pereira, Nimer Adeeb

Background: The comparative efficacy and safety of first-generation flow diverters (FDs), Pipeline Embolization Device (PED) (Medtronic, Irvine, California), Silk (Balt Extrusion, Montmorency, France), Flow Re-direction Endoluminal Device (FRED) (Microvention, Tustin, California), and Surpass Streamline (Stryker Neurovascular, Fremont, California), is not directly established and largely inferred.

Purpose: This study aimed to compare the efficacy of different FDs in treating sidewall ICA intracranial aneurysms.

Methods: We conducted a retrospective review of prospectively maintained databases from eighteen academic institutions from 2009-2016, comprising 444 patients treated with one of four devices for sidewall ICA aneurysms. Data on demographics, aneurysm characteristics, treatment outcomes, and complications were analyzed. Angiographic and clinical outcomes were assessed using various imaging modalities and modified Rankin Scale (mRS). Propensity score weighting was employed to balance confounding variables. The data analysis used Kaplan-Meier curves, logistic regression, and Cox proportional-hazards regression.

Results: While there were no significant differences in retreatment rates, functional outcomes (mRS 0-1), and thromboembolic complications between the four devices, the probability of achieving adequate occlusion at the last follow-up was highest in Surpass device (HR: 4.59; CI: 2.75-7.66, p < 0.001), followed by FRED (HR: 2.23; CI: 1.44-3.46, p < 0.001), PED (HR: 1.72; CI: 1.10-2.70, p = 0.018), and Silk (HR: 1.0 ref. standard). The only hemorrhagic complications were with Surpass (1%).

Conclusion: All the first-generation devices achieved good clinical outcomes and retreatment rates in treating ICA sidewall aneurysms. Prospective studies are needed to explore the nuanced differences between these devices in the long term.

背景:第一代血流分流器(FDs)--管道栓塞装置(PED)(美敦力,加利福尼亚州欧文)、丝绸(Balt Extrusion,法国蒙莫朗西)、血流再定向腔内装置(FRED)(Microvention,加利福尼亚州塔斯廷)和 Surpass Streamline(史赛克神经血管公司,加利福尼亚州弗里蒙特)--的疗效和安全性比较尚未直接确定,主要是推断。目的:本研究旨在比较不同 FD 治疗侧壁 ICA 颅内动脉瘤的疗效:我们对 2009-2016 年间 18 家学术机构的前瞻性数据库进行了回顾性审查,其中包括使用四种装置之一治疗侧壁 ICA 动脉瘤的 444 例患者。分析了有关人口统计学、动脉瘤特征、治疗效果和并发症的数据。血管造影和临床结果采用各种成像模式和改良Rankin量表(mRS)进行评估。采用倾向评分加权法平衡混杂变量。数据分析采用了卡普兰-梅耶曲线、逻辑回归和考克斯比例危险回归:结果:虽然四种装置在再治疗率、功能预后(mRS 0-1)和血栓栓塞并发症方面没有明显差异,但 Surpass 装置在最后一次随访时实现充分闭塞的概率最高(HR:4.59;CI:2.75-7.66,p):所有第一代装置在治疗 ICA 侧壁动脉瘤方面都取得了良好的临床效果和再治疗率。需要进行前瞻性研究,以探索这些设备在长期治疗中的细微差别。
{"title":"Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: a Retrospective, Multicenter Study.","authors":"Adam A Dmytriw, Hamza Adel Salim, Basel Musmar, Nicole M Cancelliere, Christoph J Griessenauer, Robert W Regenhardt, Jesse Jones, Vincent Tutino, Zuha Hasan, Nicola Limbucci, Sovann V Lay, Julian Spears, James D Rabinov, Mark R Harrigan, Adnan H Siddiqui, Elad I Levy, Christopher J Stapleton, Leonardo Renieri, Christophe Cognard, Hamza Shaikh, Anna Luisa Kühn, Markus A Möhlenbruch, Stavropoula I Tjoumakaris, Pascal Jabbour, Philipp Taussky, Fabio Settecase, Manraj K S Heran, Anh Nguyen, David Volders, Pablo Harker, Diego A Devia, Ajit S Puri, Marios Psychogios, Juan C Puentes, Giuseppe Leone, Giuseppe Buono, Margherita Tarantino, Mario Muto, Francesco Briganti, Shamsher Dalal, Vamsi Gontu, Rodolfo E Alcedo Guardia, Juan C Vicenty-Padilla, Patrick Brouwer, Matthias H Schmidt, Clemens Schirmer, Gwynedd E Pickett, Tommy Andersson, Michael Söderman, Thomas R Marotta, Hugo Cuellar-Saenz, Ajith J Thomas, Aman B Patel, Vitor Mendes Pereira, Nimer Adeeb","doi":"10.1007/s00062-024-01435-x","DOIUrl":"10.1007/s00062-024-01435-x","url":null,"abstract":"<p><strong>Background: </strong>The comparative efficacy and safety of first-generation flow diverters (FDs), Pipeline Embolization Device (PED) (Medtronic, Irvine, California), Silk (Balt Extrusion, Montmorency, France), Flow Re-direction Endoluminal Device (FRED) (Microvention, Tustin, California), and Surpass Streamline (Stryker Neurovascular, Fremont, California), is not directly established and largely inferred.</p><p><strong>Purpose: </strong>This study aimed to compare the efficacy of different FDs in treating sidewall ICA intracranial aneurysms.</p><p><strong>Methods: </strong>We conducted a retrospective review of prospectively maintained databases from eighteen academic institutions from 2009-2016, comprising 444 patients treated with one of four devices for sidewall ICA aneurysms. Data on demographics, aneurysm characteristics, treatment outcomes, and complications were analyzed. Angiographic and clinical outcomes were assessed using various imaging modalities and modified Rankin Scale (mRS). Propensity score weighting was employed to balance confounding variables. The data analysis used Kaplan-Meier curves, logistic regression, and Cox proportional-hazards regression.</p><p><strong>Results: </strong>While there were no significant differences in retreatment rates, functional outcomes (mRS 0-1), and thromboembolic complications between the four devices, the probability of achieving adequate occlusion at the last follow-up was highest in Surpass device (HR: 4.59; CI: 2.75-7.66, p < 0.001), followed by FRED (HR: 2.23; CI: 1.44-3.46, p < 0.001), PED (HR: 1.72; CI: 1.10-2.70, p = 0.018), and Silk (HR: 1.0 ref. standard). The only hemorrhagic complications were with Surpass (1%).</p><p><strong>Conclusion: </strong>All the first-generation devices achieved good clinical outcomes and retreatment rates in treating ICA sidewall aneurysms. Prospective studies are needed to explore the nuanced differences between these devices in the long term.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"907-917"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141635174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Severe Intracranial Stenoses with Ischemic Stroke in Neuroborreliosis-associated Cerebral Vasculitis: Endovascular Treatment Strategies and Literature Review. 神经嗜血杆菌相关性脑血管炎的多发性严重颅内狭窄并缺血性中风:血管内治疗策略和文献综述。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-12 DOI: 10.1007/s00062-024-01447-7
Kamran Hajiyev, Michael Forsting, Alexandru Cimpoca, Ali Khanafer, Hansjörg Bäzner, Hans Henkes

Introduction: Neuroborreliosis is the disseminated form of Lyme borreliosis and refers to the involvement of the central nervous system by Borrelia burgdorferi sensu lato spirochetes. Several reports suggest its emergence as a potential cause of cerebral vasculitis and stroke in children and young adults. The objective of this paper is to highlight endovascular treatment options within this context.

Methods: The medicinal and endovascular treatments of three patients-two adults and one child-with ischemic stroke resulting from neuroborreliosis-associated severe cerebral vasculitis were retrospectively assessed. Detailed descriptions of the clinical course, treatments, and follow-up data for each patient are provided. Additionally, a literature review focusing on endovascular treatment options within this topic was conducted.

Results: Both endovascular and medicinal treatments resulted in excellent clinical outcomes in all three patients, with no observed periprocedural complications. Significant clinical improvement was noted during mid-term follow-up. Follow-up angiographies confirmed stent patency.

Conclusion: Endovascular interventions as a bailout strategy may enhance clinical outcomes in patients with vascular complications of neuroborreliosis, especially when medicinal therapy alone fails to achieve further improvement. In the setting of severe ischemic stroke with sub-occlusive large vessel stenosis or occlusion, the cause of which is often unknown, it should be considered to prioritize prompt endovascular treatment, even if neuroborreliosis is suspected on admission.

导言:神经源性疾病是莱姆病的播散型,指的是中枢神经系统受伯多菲氏包柔氏螺旋体(Borrelia burgdorferi sensu lato spirochetes)的侵袭。多份报告显示,它是儿童和青壮年脑血管炎和中风的潜在病因。本文旨在强调在此背景下的血管内治疗方案:方法:回顾性评估了三名因神经包虫病相关重症脑血管炎导致缺血性中风的患者--两名成人和一名儿童--的药物和血管内治疗情况。文中详细描述了每位患者的临床过程、治疗方法和随访数据。此外,还对该主题下的血管内治疗方案进行了文献综述:结果:血管内治疗和药物治疗均为三名患者带来了良好的临床疗效,且未观察到围术期并发症。在中期随访中,临床症状明显改善。随访血管造影证实支架通畅:结论:血管内介入治疗作为一种救助策略,可提高神经源性疾病血管并发症患者的临床疗效,尤其是在单纯药物治疗无法进一步改善病情的情况下。在严重缺血性中风伴有亚闭塞性大血管狭窄或闭塞的情况下,即使入院时怀疑有神经源性脑病,也应考虑优先考虑及时进行血管内治疗,因为其原因往往不明。
{"title":"Multiple Severe Intracranial Stenoses with Ischemic Stroke in Neuroborreliosis-associated Cerebral Vasculitis: Endovascular Treatment Strategies and Literature Review.","authors":"Kamran Hajiyev, Michael Forsting, Alexandru Cimpoca, Ali Khanafer, Hansjörg Bäzner, Hans Henkes","doi":"10.1007/s00062-024-01447-7","DOIUrl":"10.1007/s00062-024-01447-7","url":null,"abstract":"<p><strong>Introduction: </strong>Neuroborreliosis is the disseminated form of Lyme borreliosis and refers to the involvement of the central nervous system by Borrelia burgdorferi sensu lato spirochetes. Several reports suggest its emergence as a potential cause of cerebral vasculitis and stroke in children and young adults. The objective of this paper is to highlight endovascular treatment options within this context.</p><p><strong>Methods: </strong>The medicinal and endovascular treatments of three patients-two adults and one child-with ischemic stroke resulting from neuroborreliosis-associated severe cerebral vasculitis were retrospectively assessed. Detailed descriptions of the clinical course, treatments, and follow-up data for each patient are provided. Additionally, a literature review focusing on endovascular treatment options within this topic was conducted.</p><p><strong>Results: </strong>Both endovascular and medicinal treatments resulted in excellent clinical outcomes in all three patients, with no observed periprocedural complications. Significant clinical improvement was noted during mid-term follow-up. Follow-up angiographies confirmed stent patency.</p><p><strong>Conclusion: </strong>Endovascular interventions as a bailout strategy may enhance clinical outcomes in patients with vascular complications of neuroborreliosis, especially when medicinal therapy alone fails to achieve further improvement. In the setting of severe ischemic stroke with sub-occlusive large vessel stenosis or occlusion, the cause of which is often unknown, it should be considered to prioritize prompt endovascular treatment, even if neuroborreliosis is suspected on admission.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"959-972"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11564264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wernicke Encephalopathy: Typical and Atypical Findings in Alcoholics and Non-Alcoholics and Correlation with Clinical Symptoms. Wernicke脑病:酒精中毒者和非酒精中毒者的典型和非典型发现以及与临床症状的相关性。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-16 DOI: 10.1007/s00062-024-01434-y
C T Arendt, C Uckermark, L Kovacheva, F Lieschke, R Golbach, S Edwin Thanarajah, E Hattingen, S Weidauer
<p><strong>Purpose: </strong>Clinical diagnosis of Wernicke encephalopathy (WE) can be challenging due to incomplete presentation of the classical triad. The aim was to provide an update on the relevance of standard MRI and to put typical and atypical imaging findings into context with clinical features.</p><p><strong>Methods: </strong>In this two-center retrospective observational study, the local radiology information system was searched for consecutive patients with clinical or imaging suspicion of WE. Two independent raters evaluated T2-weighted imaging (WI), fluid-attenuation inversion recovery (FLAIR), diffusion WI (DWI), T2*WI and/or susceptibility WI (SWI), and contrast-enhanced (CE)-T1WI, and noted the involvement of typical (i.e., mammillary bodies (MB), periaqueductal grey (PAG), thalamus, hypothalamus, tectal plate) and atypical (all others) lesion sites. Unusual signal patterns like hemorrhages were also documented. Reported clinical features together with the diagnostic criteria of the latest guidelines of the European Federation of Neurological Societies (EFNS) were used to test for relationships with MRI biomarkers.</p><p><strong>Results: </strong>47 patients with clinically confirmed WE were included (Jan '99-Apr '23; mean age, 53 yrs; 70% males). Interrater reliability for imaging findings was substantial (κ = 0.71), with lowest agreements for T2WI (κ = 0.85) compared to all other sequences and for PAG (κ = 0.65) compared to all other typical regions. In consensus, 77% (n = 36/47) of WE cases were rated MRI positive, with FLAIR (n = 36/47, 77%) showing the strongest relation (χ<sup>2</sup> = 47.0; P < 0.001) compared to all other sequences. Microbleeds in the MB were detected in four out of ten patients who received SWI, not visible on corresponding T2*WI. Atypical findings were observed in 23% (n = 11/47) of cases, always alongside typical findings, in both alcoholics (n = 9/44, 21%) and non-alcoholics (n = 2/3, 67%). Isolated involvement of structures, explicitly PAG (n = 4/36; 11%) or MB (n = 1/36; 3%), was present but observed less frequently than combined lesions (n = 31/36; 86%). A cut-off width of 2.5 mm for the PAG on 2D axial FLAIR was established between cases and age- and sex-matched controls. An independent association was demonstrated only between short-term memory loss and changes in the MB (OR = 2.2 [95% CI: 1.1-4.5]; P = 0.024). In retrospect, EFNS criteria were positive (≥ 2 out of 4) in every case, but its count (range, 2-4) showed no significant (P = 0.427) relationship with signal changes on standard MRI.</p><p><strong>Conclusion: </strong>The proposed sequence protocol (FLAIR, DWI, SWI and T1WI + CE) yielded good detection rates for neuroradiological findings in WE, with SWI showing microbleeds in the MB with superior detectability. However, false negative results in about a quarter of cases underline the importance of neurological alertness for the diagnosis. Awareness of atypical MRI findings should be rai
目的:由于经典三联征表现不完整,Wernicke 脑病(WE)的临床诊断可能具有挑战性。研究旨在更新标准磁共振成像的相关性,并将典型和非典型成像结果与临床特征相结合:在这项双中心回顾性观察研究中,研究人员在当地放射学信息系统中搜索了临床或影像学怀疑患有 WE 的连续患者。两名独立评分员评估了T2加权成像(WI)、流体增强反转恢复(FLAIR)、弥散WI(DWI)、T2*WI和/或易感WI(SWI)以及对比增强(CE)-T1WI,并指出了典型病变部位(即乳腺体(MB)、uctal灰质周围(PAG)、丘脑、下丘脑、构造板)和非典型病变部位(所有其他部位)。出血等异常信号模式也有记录。报告的临床特征与欧洲神经病学学会联合会(EFNS)最新指南的诊断标准被用来检验与磁共振成像生物标志物之间的关系:共纳入 47 名经临床确诊的 WE 患者(99 年 1 月至 23 年 4 月;平均年龄 53 岁;70% 为男性)。成像结果的相互间可靠性相当高(κ = 0.71),与所有其他序列相比,T2WI 的相互间可靠性最低(κ = 0.85),与所有其他典型区域相比,PAG 的相互间可靠性最低(κ = 0.65)。一致认为,77%(n = 36/47)的 WE 病例被评为 MRI 阳性,其中 FLAIR(n = 36/47,77%)显示出最强的相关性(χ2 = 47.0;P 结论:建议的序列方案(FLAIR、DWI、SWI 和 T1WI + CE)对 WE 神经放射学结果的检出率较高,其中 SWI 显示 MB 中的微出血具有更高的可检出性。然而,约四分之一的病例出现假阴性结果,这凸显了神经系统警觉性对诊断的重要性。应提高对非典型磁共振成像结果的认识,这不仅适用于非酒精中毒者。临床症状与标准磁共振成像生物标志物之间的相关性有限。
{"title":"Wernicke Encephalopathy: Typical and Atypical Findings in Alcoholics and Non-Alcoholics and Correlation with Clinical Symptoms.","authors":"C T Arendt, C Uckermark, L Kovacheva, F Lieschke, R Golbach, S Edwin Thanarajah, E Hattingen, S Weidauer","doi":"10.1007/s00062-024-01434-y","DOIUrl":"10.1007/s00062-024-01434-y","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;Clinical diagnosis of Wernicke encephalopathy (WE) can be challenging due to incomplete presentation of the classical triad. The aim was to provide an update on the relevance of standard MRI and to put typical and atypical imaging findings into context with clinical features.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this two-center retrospective observational study, the local radiology information system was searched for consecutive patients with clinical or imaging suspicion of WE. Two independent raters evaluated T2-weighted imaging (WI), fluid-attenuation inversion recovery (FLAIR), diffusion WI (DWI), T2*WI and/or susceptibility WI (SWI), and contrast-enhanced (CE)-T1WI, and noted the involvement of typical (i.e., mammillary bodies (MB), periaqueductal grey (PAG), thalamus, hypothalamus, tectal plate) and atypical (all others) lesion sites. Unusual signal patterns like hemorrhages were also documented. Reported clinical features together with the diagnostic criteria of the latest guidelines of the European Federation of Neurological Societies (EFNS) were used to test for relationships with MRI biomarkers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;47 patients with clinically confirmed WE were included (Jan '99-Apr '23; mean age, 53 yrs; 70% males). Interrater reliability for imaging findings was substantial (κ = 0.71), with lowest agreements for T2WI (κ = 0.85) compared to all other sequences and for PAG (κ = 0.65) compared to all other typical regions. In consensus, 77% (n = 36/47) of WE cases were rated MRI positive, with FLAIR (n = 36/47, 77%) showing the strongest relation (χ&lt;sup&gt;2&lt;/sup&gt; = 47.0; P &lt; 0.001) compared to all other sequences. Microbleeds in the MB were detected in four out of ten patients who received SWI, not visible on corresponding T2*WI. Atypical findings were observed in 23% (n = 11/47) of cases, always alongside typical findings, in both alcoholics (n = 9/44, 21%) and non-alcoholics (n = 2/3, 67%). Isolated involvement of structures, explicitly PAG (n = 4/36; 11%) or MB (n = 1/36; 3%), was present but observed less frequently than combined lesions (n = 31/36; 86%). A cut-off width of 2.5 mm for the PAG on 2D axial FLAIR was established between cases and age- and sex-matched controls. An independent association was demonstrated only between short-term memory loss and changes in the MB (OR = 2.2 [95% CI: 1.1-4.5]; P = 0.024). In retrospect, EFNS criteria were positive (≥ 2 out of 4) in every case, but its count (range, 2-4) showed no significant (P = 0.427) relationship with signal changes on standard MRI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The proposed sequence protocol (FLAIR, DWI, SWI and T1WI + CE) yielded good detection rates for neuroradiological findings in WE, with SWI showing microbleeds in the MB with superior detectability. However, false negative results in about a quarter of cases underline the importance of neurological alertness for the diagnosis. Awareness of atypical MRI findings should be rai","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"881-897"},"PeriodicalIF":2.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141628158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children with Congenital Heart Diseases Exhibit Altered Deep Gray Matter Structures. 先天性心脏病患儿的深层灰质结构发生变化。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-05-14 DOI: 10.1007/s00062-024-01417-z
Nils D Forkert, Sarah J MacEachern, Allison K Duh, Peter Moon, Sarah Lee, Kristen W Yeom

Background and objectives: Children with congenital heart diseases (CHDs) have an increased risk of developing neurologic deficits, even in the absence of apparent brain pathology. The aim of this work was to compare quantitative macro- and microstructural properties of subcortical gray matter structures of pediatric CHD patients with normal appearing brain magnetic resonance imaging to healthy controls.

Methods: We retrospectively reviewed children with coarctation of the aorta (COA) and hypoplastic left heart syndrome (HLHS) admitted to our hospital. We identified 24 pediatric CHD patients (17 COA, 7 HLHS) with normal-appearing brain MRI. Using an atlas-based approach, the volume and apparent diffusion coefficient (ADC) were determined for the thalamus, caudate, putamen, pallidum, hippocampus, amygdala, nucleus accumbens, cerebral white matter, cerebral cortex, and brainstem. Multivariate statistics were used to compare the extracted values to reference values from 100 typically developing children without any known cardiac or neurological diseases.

Results: Multivariate analysis of covariance using the regional ADC and volume values as dependent variables and age and sex as co-variates revealed a significant difference between pediatric CHD patients and healthy controls (p < 0.001). Post-hoc comparisons demonstrated significantly reduced brain volumes in most subcortical brain regions investigated and elevated ADC values in the thalamus for children with CHD. No significant differences were found comparing children with COA and HLHS.

Conclusions: Despite normal appearing brain MRI, children with CHD exhibit wide-spread macro-structural and regional micro-structural differences of subcortical brain structures compared to healthy controls, which could negatively impact neurodevelopment, leading to neurological deficits in childhood and beyond.

背景和目的:先天性心脏病(CHD)患儿出现神经功能障碍的风险增加,即使没有明显的脑部病变。本研究旨在将脑磁共振成像显示正常的小儿先天性心脏病患者皮层下灰质结构的宏观和微观定量特性与健康对照组进行比较:我们回顾性研究了本院收治的主动脉共动脉症(COA)和左心房发育不全综合征(HLHS)患儿。我们确定了 24 名小儿 CHD 患者(17 名 COA,7 名 HLHS),他们的脑磁共振成像显示正常。采用基于图集的方法,测定了丘脑、尾状核、普鲁士门、苍白球、海马、杏仁核、伏隔核、脑白质、大脑皮质和脑干的体积和表观弥散系数(ADC)。研究人员使用多元统计学方法,将提取的数值与 100 名发育正常且无任何已知心脏或神经系统疾病的儿童的参考值进行比较:结果:以区域 ADC 值和容积值为因变量,以年龄和性别为协变量的多变量协方差分析表明,小儿先天性心脏病患者与健康对照组之间存在显著差异(p 结论:尽管小儿先天性心脏病患者的脑部 MRI 表现正常,但他们的脑干和大脑皮质却有不同程度的病变:尽管脑磁共振成像显示正常,但与健康对照组相比,患有先天性心脏病的儿童大脑皮层下结构表现出广泛的宏观结构和区域微观结构差异,这可能会对神经发育产生负面影响,导致儿童期及以后的神经功能缺陷。
{"title":"Children with Congenital Heart Diseases Exhibit Altered Deep Gray Matter Structures.","authors":"Nils D Forkert, Sarah J MacEachern, Allison K Duh, Peter Moon, Sarah Lee, Kristen W Yeom","doi":"10.1007/s00062-024-01417-z","DOIUrl":"10.1007/s00062-024-01417-z","url":null,"abstract":"<p><strong>Background and objectives: </strong>Children with congenital heart diseases (CHDs) have an increased risk of developing neurologic deficits, even in the absence of apparent brain pathology. The aim of this work was to compare quantitative macro- and microstructural properties of subcortical gray matter structures of pediatric CHD patients with normal appearing brain magnetic resonance imaging to healthy controls.</p><p><strong>Methods: </strong>We retrospectively reviewed children with coarctation of the aorta (COA) and hypoplastic left heart syndrome (HLHS) admitted to our hospital. We identified 24 pediatric CHD patients (17 COA, 7 HLHS) with normal-appearing brain MRI. Using an atlas-based approach, the volume and apparent diffusion coefficient (ADC) were determined for the thalamus, caudate, putamen, pallidum, hippocampus, amygdala, nucleus accumbens, cerebral white matter, cerebral cortex, and brainstem. Multivariate statistics were used to compare the extracted values to reference values from 100 typically developing children without any known cardiac or neurological diseases.</p><p><strong>Results: </strong>Multivariate analysis of covariance using the regional ADC and volume values as dependent variables and age and sex as co-variates revealed a significant difference between pediatric CHD patients and healthy controls (p < 0.001). Post-hoc comparisons demonstrated significantly reduced brain volumes in most subcortical brain regions investigated and elevated ADC values in the thalamus for children with CHD. No significant differences were found comparing children with COA and HLHS.</p><p><strong>Conclusions: </strong>Despite normal appearing brain MRI, children with CHD exhibit wide-spread macro-structural and regional micro-structural differences of subcortical brain structures compared to healthy controls, which could negatively impact neurodevelopment, leading to neurological deficits in childhood and beyond.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"771-778"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140923602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haberland Syndrome (Encephalocraniocutaneous Lipomatosis) with Development of Diffuse Leptomeningeal Glioneural Tumor (DL-GNT) during Adolescence. 哈伯兰综合征(脑颅皮脂肪瘤病)伴青少年期弥漫性脑膜神经胶质瘤(DL-GNT)的发展。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-02-14 DOI: 10.1007/s00062-024-01389-0
Suely Fazio Ferraciolli, Mario Tortora, Luis Felipe de Souza Godoy, Yuri Reis Casal, Leandro Tavares Lucato
{"title":"Haberland Syndrome (Encephalocraniocutaneous Lipomatosis) with Development of Diffuse Leptomeningeal Glioneural Tumor (DL-GNT) during Adolescence.","authors":"Suely Fazio Ferraciolli, Mario Tortora, Luis Felipe de Souza Godoy, Yuri Reis Casal, Leandro Tavares Lucato","doi":"10.1007/s00062-024-01389-0","DOIUrl":"10.1007/s00062-024-01389-0","url":null,"abstract":"","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"973-976"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139730820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the Diagnostic Performance of GPT-4-based ChatGPT, GPT-4V-based ChatGPT, and Radiologists in Challenging Neuroradiology Cases. 比较基于 GPT-4 的 ChatGPT、基于 GPT-4V 的 ChatGPT 和放射科医生在神经放射学疑难病例中的诊断效果。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-12-01 Epub Date: 2024-05-28 DOI: 10.1007/s00062-024-01426-y
Daisuke Horiuchi, Hiroyuki Tatekawa, Tatsushi Oura, Satoshi Oue, Shannon L Walston, Hirotaka Takita, Shu Matsushita, Yasuhito Mitsuyama, Taro Shimono, Yukio Miki, Daiju Ueda

Purpose: To compare the diagnostic performance among Generative Pre-trained Transformer (GPT)-4-based ChatGPT, GPT‑4 with vision (GPT-4V) based ChatGPT, and radiologists in challenging neuroradiology cases.

Methods: We collected 32 consecutive "Freiburg Neuropathology Case Conference" cases from the journal Clinical Neuroradiology between March 2016 and December 2023. We input the medical history and imaging findings into GPT-4-based ChatGPT and the medical history and images into GPT-4V-based ChatGPT, then both generated a diagnosis for each case. Six radiologists (three radiology residents and three board-certified radiologists) independently reviewed all cases and provided diagnoses. ChatGPT and radiologists' diagnostic accuracy rates were evaluated based on the published ground truth. Chi-square tests were performed to compare the diagnostic accuracy of GPT-4-based ChatGPT, GPT-4V-based ChatGPT, and radiologists.

Results: GPT‑4 and GPT-4V-based ChatGPTs achieved accuracy rates of 22% (7/32) and 16% (5/32), respectively. Radiologists achieved the following accuracy rates: three radiology residents 28% (9/32), 31% (10/32), and 28% (9/32); and three board-certified radiologists 38% (12/32), 47% (15/32), and 44% (14/32). GPT-4-based ChatGPT's diagnostic accuracy was lower than each radiologist, although not significantly (all p > 0.07). GPT-4V-based ChatGPT's diagnostic accuracy was also lower than each radiologist and significantly lower than two board-certified radiologists (p = 0.02 and 0.03) (not significant for radiology residents and one board-certified radiologist [all p > 0.09]).

Conclusion: While GPT-4-based ChatGPT demonstrated relatively higher diagnostic performance than GPT-4V-based ChatGPT, the diagnostic performance of GPT‑4 and GPT-4V-based ChatGPTs did not reach the performance level of either radiology residents or board-certified radiologists in challenging neuroradiology cases.

目的:比较基于生成预训练变换器(GPT)-4 的 ChatGPT、基于视觉的 GPT-4 的 ChatGPT 和放射科医生在具有挑战性的神经放射学病例中的诊断性能:我们从《临床神经放射学》杂志中收集了 2016 年 3 月至 2023 年 12 月间的 32 个连续的 "弗莱堡神经病理学病例会议 "病例。我们将病史和影像检查结果输入基于 GPT-4 的 ChatGPT,将病史和影像输入基于 GPT-4V 的 ChatGPT,然后两者为每个病例生成诊断。六位放射科医生(三位放射科住院医师和三位经委员会认证的放射科医生)独立审查所有病例并提供诊断。根据已公布的基本事实对 ChatGPT 和放射科医生的诊断准确率进行了评估。对基于 GPT-4 的 ChatGPT、基于 GPT-4V 的 ChatGPT 和放射医师的诊断准确率进行了卡方检验:结果:基于 GPT-4 和 GPT-4V 的 ChatGPT 的准确率分别为 22%(7/32)和 16%(5/32)。放射科医生的准确率如下:三位放射科住院医生分别为 28%(9/32)、31%(10/32)和 28%(9/32);三位经委员会认证的放射科医生分别为 38%(12/32)、47%(15/32)和 44%(14/32)。基于 GPT-4 的 ChatGPT 诊断准确率低于每位放射科医生,但差异不明显(均 p > 0.07)。基于 GPT-4V 的 ChatGPT 诊断准确性也低于每位放射科医生,且明显低于两位获得医学会认证的放射科医生(P = 0.02 和 0.03)(放射科住院医师和一位获得医学会认证的放射科医生的诊断准确性不显著[所有 P > 0.09]):结论:虽然基于 GPT-4 的 ChatGPT 的诊断性能相对高于基于 GPT-4V 的 ChatGPT,但在具有挑战性的神经放射学病例中,基于 GPT-4 和 GPT-4V 的 ChatGPT 的诊断性能并未达到放射科住院医师或具有医师资格的放射科医师的性能水平。
{"title":"Comparing the Diagnostic Performance of GPT-4-based ChatGPT, GPT-4V-based ChatGPT, and Radiologists in Challenging Neuroradiology Cases.","authors":"Daisuke Horiuchi, Hiroyuki Tatekawa, Tatsushi Oura, Satoshi Oue, Shannon L Walston, Hirotaka Takita, Shu Matsushita, Yasuhito Mitsuyama, Taro Shimono, Yukio Miki, Daiju Ueda","doi":"10.1007/s00062-024-01426-y","DOIUrl":"10.1007/s00062-024-01426-y","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the diagnostic performance among Generative Pre-trained Transformer (GPT)-4-based ChatGPT, GPT‑4 with vision (GPT-4V) based ChatGPT, and radiologists in challenging neuroradiology cases.</p><p><strong>Methods: </strong>We collected 32 consecutive \"Freiburg Neuropathology Case Conference\" cases from the journal Clinical Neuroradiology between March 2016 and December 2023. We input the medical history and imaging findings into GPT-4-based ChatGPT and the medical history and images into GPT-4V-based ChatGPT, then both generated a diagnosis for each case. Six radiologists (three radiology residents and three board-certified radiologists) independently reviewed all cases and provided diagnoses. ChatGPT and radiologists' diagnostic accuracy rates were evaluated based on the published ground truth. Chi-square tests were performed to compare the diagnostic accuracy of GPT-4-based ChatGPT, GPT-4V-based ChatGPT, and radiologists.</p><p><strong>Results: </strong>GPT‑4 and GPT-4V-based ChatGPTs achieved accuracy rates of 22% (7/32) and 16% (5/32), respectively. Radiologists achieved the following accuracy rates: three radiology residents 28% (9/32), 31% (10/32), and 28% (9/32); and three board-certified radiologists 38% (12/32), 47% (15/32), and 44% (14/32). GPT-4-based ChatGPT's diagnostic accuracy was lower than each radiologist, although not significantly (all p > 0.07). GPT-4V-based ChatGPT's diagnostic accuracy was also lower than each radiologist and significantly lower than two board-certified radiologists (p = 0.02 and 0.03) (not significant for radiology residents and one board-certified radiologist [all p > 0.09]).</p><p><strong>Conclusion: </strong>While GPT-4-based ChatGPT demonstrated relatively higher diagnostic performance than GPT-4V-based ChatGPT, the diagnostic performance of GPT‑4 and GPT-4V-based ChatGPTs did not reach the performance level of either radiology residents or board-certified radiologists in challenging neuroradiology cases.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"779-787"},"PeriodicalIF":4.6,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mismatch Vs No Mismatch in Large Core-A Matter of Definition. 大核心中的错配与无错配--定义问题。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-17 DOI: 10.1007/s00062-024-01470-8
Vivek Yedavalli, Hamza Adel Salim, Dhairya A Lakhani, Janet Mei, Aneri Balar, Basel Musmar, Nimer Adeeb, Meisam Hoseinyazdi, Licia Luna, Francis Deng, Nathan Z Hyson, Adam A Dmytriw, Adrien Guenego, Hanzhang Lu, Victor C Urrutia, Kambiz Nael, Elisabeth B Marsh, Raf Llinas, Argye E Hillis, Max Wintermark, Tobias D Faizy, Jeremy J Heit, Gregory W Albers

Background: Endovascular thrombectomy (EVT) has shown promise in randomized controlled trials (RCTs) for large ischemic core stroke patients, yet variability in core definition and onset-to-imaging time creates heterogeneity in outcomes. This study aims to clarify the prevalence and implications of core-perfusion mismatch (MM) versus no mismatch (No MM) in such patients, utilizing established imaging criteria.

Methods: A retrospective cohort study was conducted including patients from 7/29/2019 to 1/29/2023, with data extracted from a continuously maintained database. Patients were eligible if they met criteria including multimodal CT imaging performed within 24 h from last known well (LKW), AIS-LVO diagnosis, and ischemic core size defined by specific rCBF thresholds. Mismatch was assessed based on different operational definitions from the EXTEND and DEFUSE 3 trials.

Results: Fifty-two patients were included, with various time windows from LKW. Using EXTEND criteria, a significant portion of early window patients exhibited MM; however, fewer patients met MM criteria in the late window. Defining MM using DEFUSE 3 criteria yielded similar patterns, but with overall lower MM prevalence in the late window. When employing rCBF <38% as a surrogate for ischemic core, a higher percentage of patients were classified as MM across both time windows compared to rCBF <30%.

Conclusion: The prevalence of MM in large ischemic core patients varies significantly depending on the imaging criteria and time from LKW. Notably, MM was more prevalent in the early time window across all criteria used. Additional RCTs are needed to determine if this definition of MM identifies patients who will benefit most from EVT.

背景:在随机对照试验(RCT)中,血管内血栓切除术(EVT)已显示出治疗大面积缺血性核心卒中患者的前景,但核心定义和发病到成像时间的差异造成了结果的异质性。本研究旨在利用已建立的成像标准,明确此类患者中核心-灌注错配(MM)与无错配(No MM)的发生率和影响:从持续维护的数据库中提取数据,对2019年7月29日至2023年1月29日期间的患者进行回顾性队列研究。符合标准的患者包括:在最后一次已知痊愈(LKW)后 24 小时内进行的多模态 CT 成像、AIS-LVO 诊断和由特定 rCBF 阈值定义的缺血核心大小。根据 EXTEND 和 DEFUSE 3 试验的不同操作定义对不匹配进行评估:研究共纳入了 52 名患者,他们的时间窗口与 LKW 不同。根据 EXTEND 标准,相当一部分早期窗口期患者表现出 MM;但在晚期窗口期符合 MM 标准的患者较少。使用 DEFUSE 3 标准定义 MM 也得出了类似的模式,但晚期窗口期 MM 的发病率总体较低。结论:大面积缺血核心区患者的 MM 患病率因成像标准和距离 LKW 的时间不同而存在显著差异。值得注意的是,在所有使用的标准中,MM 在早期时间窗更为普遍。需要进行更多的 RCT 研究,以确定这种 MM 定义是否能识别出从 EVT 中获益最多的患者。
{"title":"Mismatch Vs No Mismatch in Large Core-A Matter of Definition.","authors":"Vivek Yedavalli, Hamza Adel Salim, Dhairya A Lakhani, Janet Mei, Aneri Balar, Basel Musmar, Nimer Adeeb, Meisam Hoseinyazdi, Licia Luna, Francis Deng, Nathan Z Hyson, Adam A Dmytriw, Adrien Guenego, Hanzhang Lu, Victor C Urrutia, Kambiz Nael, Elisabeth B Marsh, Raf Llinas, Argye E Hillis, Max Wintermark, Tobias D Faizy, Jeremy J Heit, Gregory W Albers","doi":"10.1007/s00062-024-01470-8","DOIUrl":"10.1007/s00062-024-01470-8","url":null,"abstract":"<p><strong>Background: </strong>Endovascular thrombectomy (EVT) has shown promise in randomized controlled trials (RCTs) for large ischemic core stroke patients, yet variability in core definition and onset-to-imaging time creates heterogeneity in outcomes. This study aims to clarify the prevalence and implications of core-perfusion mismatch (MM) versus no mismatch (No MM) in such patients, utilizing established imaging criteria.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted including patients from 7/29/2019 to 1/29/2023, with data extracted from a continuously maintained database. Patients were eligible if they met criteria including multimodal CT imaging performed within 24 h from last known well (LKW), AIS-LVO diagnosis, and ischemic core size defined by specific rCBF thresholds. Mismatch was assessed based on different operational definitions from the EXTEND and DEFUSE 3 trials.</p><p><strong>Results: </strong>Fifty-two patients were included, with various time windows from LKW. Using EXTEND criteria, a significant portion of early window patients exhibited MM; however, fewer patients met MM criteria in the late window. Defining MM using DEFUSE 3 criteria yielded similar patterns, but with overall lower MM prevalence in the late window. When employing rCBF <38% as a surrogate for ischemic core, a higher percentage of patients were classified as MM across both time windows compared to rCBF <30%.</p><p><strong>Conclusion: </strong>The prevalence of MM in large ischemic core patients varies significantly depending on the imaging criteria and time from LKW. Notably, MM was more prevalent in the early time window across all criteria used. Additional RCTs are needed to determine if this definition of MM identifies patients who will benefit most from EVT.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Neuroradiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1